Clinical Trial Update: Pharmacokinetics, Safety, and Tolerability of SYN-020 [Phase 1]

View source ↗

Summary

Phase 1 study evaluating pharmacokinetics, safety, and tolerability of SYN-020 in radiation-induced enteritis; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Radiation Enteritis

Drugs mentioned

• SYN-020

Snippet

Sponsor: Theriva Biologics, Inc. | Conditions: Enteritis Caused by Radiation (Disorder) | Phase 1 | Status: COMPLETED